202 related articles for article (PubMed ID: 26883876)
1. Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway.
Bommarito D; Martin A; Forcade E; Nastke MD; Ritz J; Bellucci R
Cancer Immunol Immunother; 2016 Mar; 65(3):355-66. PubMed ID: 26883876
[TBL] [Abstract][Full Text] [Related]
2. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.
Bellucci R; Nguyen HN; Martin A; Heinrichs S; Schinzel AC; Hahn WC; Ritz J
J Clin Invest; 2012 Jul; 122(7):2369-83. PubMed ID: 22684105
[TBL] [Abstract][Full Text] [Related]
4. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.
Yea SS; So L; Mallya S; Lee J; Rajasekaran K; Malarkannan S; Fruman DA
PLoS One; 2014; 9(6):e99486. PubMed ID: 24915189
[TBL] [Abstract][Full Text] [Related]
6. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
7. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells.
Raulet DH; Marcus A; Coscoy L
Immunol Rev; 2017 Nov; 280(1):93-101. PubMed ID: 29027233
[TBL] [Abstract][Full Text] [Related]
9. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
10. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
[TBL] [Abstract][Full Text] [Related]
11. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
[TBL] [Abstract][Full Text] [Related]
12. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
[TBL] [Abstract][Full Text] [Related]
13. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
Tokuyama M; Lorin C; Delebecque F; Jung H; Raulet DH; Coscoy L
PLoS Pathog; 2011 Sep; 7(9):e1002265. PubMed ID: 21966273
[TBL] [Abstract][Full Text] [Related]
14. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
Veneziani I; Infante P; Ferretti E; Melaiu O; Battistelli C; Lucarini V; Compagnone M; Nicoletti C; Castellano A; Petrini S; Ognibene M; Pezzolo A; Di Marcotullio L; Bei R; Moretta L; Pistoia V; Fruci D; Barnaba V; Locatelli F; Cifaldi L
Cancer Immunol Res; 2021 Feb; 9(2):170-183. PubMed ID: 33303573
[TBL] [Abstract][Full Text] [Related]
16. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib.
Hassold N; Seystahl K; Kempf K; Urlaub D; Zekl M; Einsele H; Watzl C; Wischhusen J; Seggewiss-Bernhardt R
Int J Cancer; 2012 Sep; 131(6):E916-27. PubMed ID: 22419518
[TBL] [Abstract][Full Text] [Related]
18. Screening for Active Compounds Targeting Human Natural Killer Cell Activation Identifying Daphnetin as an Enhancer for IFN-γ Production and Direct Cytotoxicity.
Yao B; Yang Q; Yang Y; Li Y; Peng H; Wu S; Wang L; Zhang S; Huang M; Wang E; Xiong P; Luo T; Li L; Jia S; Deng Y; Deng Y
Front Immunol; 2021; 12():680611. PubMed ID: 34956168
[TBL] [Abstract][Full Text] [Related]
19. PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D-mediated activation.
Rojas JM; Spada R; Sanz-Ortega L; Morillas L; Mejías R; Mulens-Arias V; Pérez-Yagüe S; Barber DF
J Leukoc Biol; 2016 Dec; 100(6):1285-1296. PubMed ID: 27381007
[TBL] [Abstract][Full Text] [Related]
20. Effects of PI3K Inhibition on Afucosylated Antibody-Driven FcγRIIIa Events and Phospho-S6 Activity in NK Cells.
Romeo V; Gierke S; Edgar KA; Liu SD
J Immunol; 2019 Jul; 203(1):137-147. PubMed ID: 31092639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]